ARCHIVES

Challoner: We Recommended FDA Replace 510(k) Clearance

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Role Broadened By Upton; Asked To Consider All Data In Risk Assessment

November 11, 1977

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

Diabetes Associated With Greater Risk Of Cancer

December 28, 2007

Cancer Society, With Level Budget, Cuts On More Money to Fund “Pay Ifs” In FY92

March 27, 1992

Under A Flat Budget, NIH Suspends Grant Increases, May restore Funds Later.

November 24, 2000

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007